Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per-Olof Eriksson

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
JPEN. Journal of Parenteral and Enteral Nutrition|October 27, 2021
Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowelJohannes Reiner, Peggy Berlin, Jascha Held, et al.
Journal of Medicinal Chemistry|November 11, 2025
Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin AnalogueHenrik Fischer Munch, Rasmus Just, Jesper Mosolff Mathiesen, et al.
Plos One|January 29, 2015
Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug designOla Fjellström, Sibel Akkaya, Hans-Georg Beisel, et al.
RSC Medicinal Chemistry|November 3, 2022
Fragment screening at AstraZeneca: developing the next generation biophysics fragment setSimon C C Lucas, Ulf Börjesson, Mark J Bostock, et al.
The Journal of Biological Chemistry|March 6, 2020
Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain functionJenny Sandmark, Anna Tigerström, Tomas Akerud, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
JPEN. Journal of Parenteral and Enteral Nutrition|October 27, 2021
Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowelJohannes Reiner, Peggy Berlin, Jascha Held, et al.
Journal of Medicinal Chemistry|November 11, 2025
Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin AnalogueHenrik Fischer Munch, Rasmus Just, Jesper Mosolff Mathiesen, et al.
Plos One|January 29, 2015
Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug designOla Fjellström, Sibel Akkaya, Hans-Georg Beisel, et al.
RSC Medicinal Chemistry|November 3, 2022
Fragment screening at AstraZeneca: developing the next generation biophysics fragment setSimon C C Lucas, Ulf Börjesson, Mark J Bostock, et al.
The Journal of Biological Chemistry|March 6, 2020
Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain functionJenny Sandmark, Anna Tigerström, Tomas Akerud, et al.
Pageof 6